Skip to main content
OpenTrials
Completed

NCT Number: NCT02173132

Acetyl-L-Carnitine Reduces Perceived Work Stress and Improves Work Ability and Work Performance in Hepatic Encephalopathy

This study evaluated the effects of acetyl-L-carnitine treatment on Perceived Work Stress, Work Ability and Work Performance in subjects with Hepatic Encephalopathy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

33 year–68 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University of Catania

Catania, 95126, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • overt hepatic encephalopathy (HE) or a history of overt HE

Exclusion criteria

  • history of recent alcohol intake; infection; recent antibiotic use or gastrointestinal bleeding; history of recent use of drugs affecting psychometric performances like benzodiazepines, antiepileptics or psychotropic drugs; a history of shunt surgery or transjugular intrahepatic portosystemic shunt for portal hypertension; electrolyte imbalance; renal impairment; hepatocellular carcinoma; severe medical problems such as congestive heart failure, pulmonary disease or neurological or psychiatric disorder that could influence quality of life measurement; inability to perform neuropsycological tests.

Treatment and study plan

Acetyl-L-carnitine

Drug

Placebo

Other

Primary outcomes

  1. work stress

    Time frame: 90 days

Sponsors and collaborators

Lead sponsor

University of Catania

Other

Registry information

Important dates

Study start
2010
Primary completion
2013
First posted
Jun 24, 2014
Registry last updated
Jun 24, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.